Dyne Therapeutics, Inc. EV/FCF

EV/FCF of DYN for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart. A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Visit stockrow.com/DYN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/FCF of Dyne Therapeutics, Inc.

Most recent EV/FCFof DYN including historical data for past 10 years.

Interactive Chart of EV/FCF of Dyne Therapeutics, Inc.

Business Profile of Dyne Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology